News | Coronavirus (COVID-19) | May 06, 2020

Kubtec Partners with Surgeons to Address Breast Cancer Patients' Concerns During COVID-19

Podcast: Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano

Kubtec hosts a Podcast: Impact of COVID-19 on Breast Cancer Treatment with Andrea Madrigrano, M.D., as part of its public service campaign.

May 6, 2020 — The COVID-19 pandemic is an unprecedented global health crisis, impacting all aspects of life and society. This includes breast cancer where patients' fears are now exacerbated by the need to make critical treatment decisions against the backdrop of a healthcare system nearing its breaking point.

To allay patient concerns, Kubtec Medical Imaging is partnering with breast cancer surgeons to lead a public service campaign to ensure that breast cancer patients are kept informed during the COVID-19 pandemic. These surgeons are addressing several key topics, including what patients should do if they believe they need treatment, interim measures that are being employed when surgical procedures are delayed, and technologies being utilized when breast surgeries are performed to help dramatically reduce patients' risk of needing to return for a second surgery.

"These are extraordinary times for the U.S. healthcare system, with hospitals and doctors having to balance the needs of patients with serious medical conditions with the need to ensure resources are available to treat COVID-19 patients," said Vikram Butani, founder and chief executive officer of Kubtec. "It is important that the public, and especially breast cancer patients, know that treatments are being administered, including lumpectomies when necessary, to ensure the best possible outcomes. Kubtec is proud to be working with leading breast cancer surgeons on this valuable public service initiative."

Hospitals and healthcare centers throughout the country are triaging breast cancer surgeries during the COVID-19 pandemic on a case-by-case basis in accordance with guidelines from the American Society of Breast Surgeons (ASBrS) to protect breast cancer patients from infection and to ensure that healthcare providers have the resources they need to treat people who become seriously ill from COVID-19.

In an interview with FOX 32 Chicago, Andrea Madrigrano, M.D., breast cancer surgeon and associate professor at Rush University Medical Center, provided assurance that breast cancer patients will continue to get the care they need: "Anybody with a new mass can get a diagnostic mammogram, get a biopsy, get a breast MRI. For women with certain types of breast cancer, surgery is still being performed, but oftentimes we're altering the course of how we're managing breast cancer."

In an interview with NBC's Bloom/News Channel 8 (WFLA) in Tampa, Charles Cox, M.D., endowed chair and professor at Morsani College of Medicine Surgery, USF Health, spoke to the importance of reducing breast cancer re-excisions during the COVID-19 outbreak and technologies available in the operating room that enable surgeons to better visualize tumors during lumpectomy procedures: "Limiting the need to take patients back for second procedures is one of the key reasons we use certain technologies. The Kubtec Mozart tomosynthesis machine creates a 3D image of the specimen, and we can actually take slices through it and see if we're close on any margin rather than having to bring patients back to the operating room."

For more information on Kubtec's COVID-19 public service campaign: https://kubtec.com/news/

Related Coronavirus Content:

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

ACC COVID-19 recommendations for the cardiovascular care team

VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

The Cardiac Implications of Novel Coronavirus

ESC Council on Hypertension Says ACE-I and ARBs Do Not Increase COVID-19 Mortality

Related Content

Radiologists of Leuwiliang General Hospital using Lunit INSIGHT CXR and INFINITT PACS G7

Radiologists of Leuwiliang General Hospital using Lunit INSIGHT CXR and Infinitt PACS G7.

News | Coronavirus (COVID-19) | January 27, 2021
January 27, 2021 — Lunit, a South Korean medical...
For years telehealth has danced at the edges of healthcare
Feature | Teleradiology | January 21, 2021 | By Jef Williams
All indications point to 2021 being the year of the return path of this boomerang event that sent us all in a differe
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density

Getty Images

Feature | Women's Health | January 20, 2021 | By Fazila Seker, Ph.D.
Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recen
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
An interview with Eric Liederman, M.D., MPH, Director of Medical Informatics for The Permanente Medical Group, in Kaiser Permanente’s Northern California Region, on the explosion of telemedicine in the COVID-19 era

Getty Images

Feature | Radiology Business | January 20, 2021 | By Melinda Taschetta-Millane
The exceptionally high dose rate of the FLASH Beam is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, "FLASH." Image courtesy of Brian Pogue, PhD

The exceptionally high dose rate of the FLASH Beam is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, "FLASH." Image courtesy of Brian Pogue, PhD

News | Linear Accelerators | January 20, 2021
January 20, 2021 — A joint team of researchers from Radiation Oncology at Dartmouth's and...